Skip to content

A study to compare the effect of blood component versus local anaesthetic in long standing ankle pain

Evaluate and compare the analgesic effect of local injection of Platelet Rich Plasma vs Bupivacaine with Triamcinolone in Chronic Achilles Tendinopathy - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106345
Enrollment
80
Registered
2026-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: Platelet Rich Plasma: Platelet Rich Plasma is injected at the local site of chronic pain in the ankle as single injection and observation will be done for twelve weeks Control Intervent

Sponsors

Pt.B.D.Sharma, PGIMS Rohtak, Haryana,124001
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients of age group of 18 to 70 years of either gender with ASA grade 1 and 2 suffering from chronic pain due to Achilles Tendinopathy for atleast three months having VAS score more than 5 without satisfactory pain relief from conservative treatment presenting to the pain clinic OPD will be included in this study after approval from Institutional Biomedical Research Ethics Committee

Exclusion criteria

Exclusion criteria: Patients with 1. History of previous local anaesthetic infiltration at the site of lesion 2. Malignancy 3. Active local infection 4. Patient on anticoagulants, antiplatelet drugs, history of bleeding disorders 5. Patients on immunosuppressants or steroids 6. Diabetes Mellitus 7. Unwillingness to participate 8. Patients on treatment for psychiatric illness 9. Pregnant and lactating women 10. Recent trauma Will be excluded from the study

Design outcomes

Primary

MeasureTime frame
Outcome will be assessed on Visual Analog Scale range from 0-10 where 0 refers to no pain and 10 refers to maximum painTimepoint: To evaluate Visual Analog Scale score for assessment of pain relief before and after Platelet Rich Plasma injection or Bupivacaine with Triamcinolone and observation will be done on day one of injection, at two weeks, at four weeks, at eight weeks and at twelve weeks

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Himani Kamboj

Pt.B.D.Sharma PGIMS, Rohtak

kambojhimani1997@gmail.com7988685400

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026